GlaxoSmithKline Plc is a healthcare group that is involved in the creation and discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter (OTC) medicines, and health-related consumer products. Its major pharmaceutical products include medicines in therapeutic areas such as respiratory, HIV, immuno-inflammation, oncology, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and dermatology. GSK’s product area includes a portfolio of vaccines, speciality, and general medicines. Vaccines help protect people from infectious diseases. Its speciality medicines unit offers medicines with life-changing potential for patients suffering from diseases, including ovarian cancer, endometrial cancer, and multiple myeloma. GSK is developing medicines for immune-mediated conditions, including the first medicine for the chronic autoimmune condition lupus. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics, and medicines for skin diseases.

GSK’s research and development (R&D) team focuses on the science related to the immune system, the use of human genetics, and the application of advanced technologies such as artificial intelligence (AI) and machine learning to provide transformational medicines and vaccines.